These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
339 related articles for article (PubMed ID: 18812049)
1. Treatment outcome and follow-up of multidrug-resistant tuberculosis patients, West Coast/Winelands, South Africa, 1992-2002. Shean KP; Willcox PA; Siwendu SN; Laserson KF; Gross L; Kammerer S; Wells CD; Holtz TH Int J Tuberc Lung Dis; 2008 Oct; 12(10):1182-9. PubMed ID: 18812049 [TBL] [Abstract][Full Text] [Related]
2. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis]. Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568 [TBL] [Abstract][Full Text] [Related]
3. Ambulatory treatment of multidrug-resistant pulmonary tuberculosis patients at a chest clinic. Kim HJ; Hong YP; Kim SJ; Lew WJ; Lee EG Int J Tuberc Lung Dis; 2001 Dec; 5(12):1129-36. PubMed ID: 11769771 [TBL] [Abstract][Full Text] [Related]
4. Self-administered, standardized regimens for multidrug-resistant tuberculosis in South Korea. Park SK; Lee WC; Lee DH; Mitnick CD; Han L; Seung KJ Int J Tuberc Lung Dis; 2004 Mar; 8(3):361-8. PubMed ID: 15139476 [TBL] [Abstract][Full Text] [Related]
5. The treatment results of patients with multidrug resistant tuberculosis and factors affecting treatment outcome. Karagöz T; Yazicioğlu Moçin O; Pazarli P; Senol T; Yetiş Duman D; Duman G; Saltürk C; Unal O; Halezeroğlu S Tuberk Toraks; 2009; 57(4):383-92. PubMed ID: 20037853 [TBL] [Abstract][Full Text] [Related]
6. Risk factors associated with default from multidrug-resistant tuberculosis treatment, South Africa, 1999-2001. Holtz TH; Lancaster J; Laserson KF; Wells CD; Thorpe L; Weyer K Int J Tuberc Lung Dis; 2006 Jun; 10(6):649-55. PubMed ID: 16776452 [TBL] [Abstract][Full Text] [Related]
7. Treatment outcomes in an integrated civilian and prison MDR-TB treatment program in Russia. Shin SS; Pasechnikov AD; Gelmanova IY; Peremitin GG; Strelis AK; Mishustin S; Barnashov A; Karpeichik Y; Andreev YG; Golubchikova VT; Tonkel TP; Yanova GV; Nikiforov M; Yedilbayev A; Mukherjee JS; Furin JJ; Barry DJ; Farmer PE; Rich ML; Keshavjee S Int J Tuberc Lung Dis; 2006 Apr; 10(4):402-8. PubMed ID: 16602404 [TBL] [Abstract][Full Text] [Related]
8. Drug-resistant tuberculosis in South African gold miners: incidence and associated factors. Churchyard GJ; Corbett EL; Kleinschmidt I; Mulder D; De Cock KM Int J Tuberc Lung Dis; 2000 May; 4(5):433-40. PubMed ID: 10815737 [TBL] [Abstract][Full Text] [Related]
9. Predictors and mortality associated with treatment default in pulmonary tuberculosis. Kliiman K; Altraja A Int J Tuberc Lung Dis; 2010 Apr; 14(4):454-63. PubMed ID: 20202304 [TBL] [Abstract][Full Text] [Related]
10. Emergence of multidrug-resistant tuberculosis in a community-based directly observed treatment programme in rural South Africa. Davies GR; Pillay M; Sturm AW; Wilkinson D Int J Tuberc Lung Dis; 1999 Sep; 3(9):799-804. PubMed ID: 10488888 [TBL] [Abstract][Full Text] [Related]
11. High levels of resistance to second-line anti-tuberculosis drugs among prisoners with pulmonary tuberculosis in Georgia. Jugheli L; Rigouts L; Shamputa IC; Bram de Rijk W; Portaels F Int J Tuberc Lung Dis; 2008 May; 12(5):561-6. PubMed ID: 18419893 [TBL] [Abstract][Full Text] [Related]
12. Treatment outcomes for HIV-uninfected patients with multidrug-resistant and extensively drug-resistant tuberculosis. Kwon YS; Kim YH; Suh GY; Chung MP; Kim H; Kwon OJ; Choi YS; Kim K; Kim J; Shim YM; Koh WJ Clin Infect Dis; 2008 Aug; 47(4):496-502. PubMed ID: 18611154 [TBL] [Abstract][Full Text] [Related]
13. Pulmonary resection in the treatment of patients with pulmonary multidrug-resistant tuberculosis in Taiwan. Chiang CY; Yu MC; Bai KJ; Suo J; Lin TP; Lee YC Int J Tuberc Lung Dis; 2001 Mar; 5(3):272-7. PubMed ID: 11326827 [TBL] [Abstract][Full Text] [Related]
14. Public-private collaboration for multidrug-resistant tuberculosis control in New York City. Munsiff SS; Ahuja SD; Li J; Driver CR Int J Tuberc Lung Dis; 2006 Jun; 10(6):639-48. PubMed ID: 16776451 [TBL] [Abstract][Full Text] [Related]
15. Outcomes of individualised treatment for multidrug-resistant tuberculosis before DOTS-plus. Ollé-Goig JE; Sandy R Int J Tuberc Lung Dis; 2005 Jul; 9(7):765-70. PubMed ID: 16013772 [TBL] [Abstract][Full Text] [Related]
16. Tuberculosis retreatment category predicts resistance in hospitalized retreatment patients in a high HIV prevalence area. Schreiber YS; Herrera AF; Wilson D; Wallengren K; Draper R; Muller J; Dawood H; Doucette S; Cameron DW; Alvarez GG Int J Tuberc Lung Dis; 2009 Oct; 13(10):1274-80. PubMed ID: 19793433 [TBL] [Abstract][Full Text] [Related]
17. Cost of treatment for multidrug-resistant tuberculosis in South Korea. Kang YA; Choi YJ; Cho YJ; Lee SM; Yoo CG; Kim YW; Han SK; Shim YS; Yim JJ Respirology; 2006 Nov; 11(6):793-8. PubMed ID: 17052310 [TBL] [Abstract][Full Text] [Related]
18. Exogenous reinfection as a cause of multidrug-resistant and extensively drug-resistant tuberculosis in rural South Africa. Andrews JR; Gandhi NR; Moodley P; Shah NS; Bohlken L; Moll AP; Pillay M; Friedland G; Sturm AW; J Infect Dis; 2008 Dec; 198(11):1582-9. PubMed ID: 18847372 [TBL] [Abstract][Full Text] [Related]
19. Treatment and follow-up of HIV-negative multidrug-resistant tuberculosis patients in an infectious diseases reference hospital, Buenos Aires, Argentina. Palmero DJ; Ambroggi M; Brea A; De Lucas M; Fulgenzi A; Martínez D; Mosca C; Musella R; Natiello M; Gonzalez C; Abbate E Int J Tuberc Lung Dis; 2004 Jun; 8(6):778-84. PubMed ID: 15182150 [TBL] [Abstract][Full Text] [Related]
20. Multidrug-resistant tuberculosis: long-term treatment outcome in the Netherlands. Geerligs WA; Van Altena R; De Lange WCM ; Van Soolingen D; Van Der Werf TS Int J Tuberc Lung Dis; 2000 Aug; 4(8):758-64. PubMed ID: 10949328 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]